Journal of Obstetrics and Gynaecology Impact Factor & Information

Publisher: Informa Healthcare

Journal description

Journal of Obstetrics and Gynaecology represents an established forum for the entire field of obstetrics and gynaecology, publishing a broad range of original, peer-reviewed papers, from scientific and clinical research to reviews relevant to practice and case reports. It also includes occasional supplements on clinical symposia. The journal continues to attract a world-wide readership thanks to the emphasis on practical applicability and its excellent record of drawing on an international base of authors. (online)

Current impact factor: 0.60

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 0.604
2012 Impact Factor 0.546
2011 Impact Factor 0.542
2010 Impact Factor 0.44
2009 Impact Factor 0.431

Impact factor over time

Impact factor
Year

Additional details

5-year impact 0.00
Cited half-life 5.30
Immediacy index 0.02
Eigenfactor 0.00
Article influence 0.00
Website Journal of Obstetrics and Gynaecology website
Other titles Journal of obstetrics and gynaecology (Online), Journal of obstetrics and gynecology
ISSN 1364-6893
OCLC 37915558
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Informa Healthcare

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author cannot archive a post-print version
  • Restrictions
    • 12 months embargo
  • Conditions
    • On author's personal website or institution website
    • Publisher copyright and source must be acknowledged
    • On a non-profit server
    • Must link to publisher version
    • Publisher's version/PDF cannot be used
    • NIH funded authors may post articles to PubMed Central for release 12 months after publication
    • Wellcome Trust authors may deposit in Europe PMC after 6 months
  • Classification
    ​ yellow

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper aims to determine if the 2003 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology and classification of vulval pain is up-to-date, according to a current and widely accepted neurobiological pain classification, which divides pain into nociceptive, inflammatory and pathological pain with the latter subdivided into neuropathic and dysfunctional pain. Nociceptive pain is protective, adaptive, high-threshold pain provoked by noxious stimuli. Inflammatory pain is protective, adaptive, low-threshold pain associated with peripheral tissue damage and inflammation. Pathological pain is non-protective, maladaptive, low-threshold pain caused by structural damage to the nervous system (neuropathic pain) or by its abnormal function (dysfunctional pain). The 2003 ISSVD vulval pain classification should be revised in terms of current neurobiological pain information. Inflammatory vulval pain occurs as a result of specific infectious, inflammatory and neoplastic disorders. Neuropathic vulval pain arises following a specific neurological disorder, responsible for structural damage to the nervous system. Vulvodynia is dysfunctional vulval pain, caused by abnormal function of the nervous system itself.
    Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1019437
  • [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of alcohol intake in women who become pregnant is similar to that found in the general population, especially in cases of unplanned pregnancies. Consequently, foetal exposure is high during the period of maximum vulnerability. The present study was carried out to determine the prenatal level of exposure to alcohol in Málaga, a Mediterranean region whose economy is based on the touristic sector (Costa del Sol). A cross-sectional, observational design was used to investigate the consumption of alcohol during pregnancy, based on a self-reporting questionnaire. A total of 451 women in the first, second or third trimesters of pregnancy were recruited. Consumption prevalences in each trimester were 40.7%, 25.5% and 17.1%. A higher educational level was associated with greater exposure to alcohol (risk ratio, 1.87 [1.30–2.69]). These results should alert the providers of obstetric care in touristic areas to the need for the adoption of adequate preventive measures.
    Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1022139
  • Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1019436
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the study was to evaluate gestational weight gain (GWG) and percentage change in body mass index (BMI) for prediction of foetal macrosomia. A total of 409 term pregnant women, of whom 86 delivered macrosomic infants (> 4000 g) and 323 delivered non-macrosomic infants were recruited for the study. GWG and body mass index at delivery were significantly higher in the macrosomic than non-macrosomic group (15.8 ± 5.6 vs 13.9 ± 5.6, and 31.4 ± 4.3 vs 29.5 ± 4.3, respectively) (p < 0.05). The receiver operating characteristic curve analysis for testing the significance of weight gain in prediction of macrosomia showed an area under curve of 0.58 (p = 0.012, 95% confidence interval [CI] = 0.52–0.65), and significance of percentage change in BMI in prediction of macrosomia revealed an area under curve of 0.52 (p = 0.51, 95% CI = 0.46–0.59). BMI percentage changes both in obese (BMI ≥ 25) and non-obese (BMI < 25) groups were not statistically significant (p > 0.05). BMI percentage change does not seem to be a strong predictor of foetal macrosomia, and GWG was not found to be an independent risk factor after multivariate regression analysis was performed.
    Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1019435
  • Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1018150
  • Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1017806
  • [Show abstract] [Hide abstract]
    ABSTRACT: A retrospective cohort study was undertaken to assess the relationship between maternal body mass index (BMI) and neonatal birth weight. Data were extracted from Aberdeen Maternity and Neonatal Databank on all deliveries (n = 94049) occurring between 1967 and 2010. Compared with mothers whose weight was in the normal range, the adjusted odds of delivering a high-birth-weight infant were 0.63 (95% confidence interval: 0.59, 0.67), 1.44 (1.39, 1.50); 1.83 (1.72, 1.95); 2.22 (2.04, 2.43) in underweight, overweight, obese and morbidly obese mothers, respectively. Similarly, the adjusted odds of delivering a low-birth-weight baby decreased with increasing maternal BMI from 1.38 (1.23, 1.55) in underweight women to 0.80 (0.72, 0.89) in overweight women; 0.78 (0.67, 0.93) in obese and 0.56 (0.44, 0.71) in morbidly obese mothers. These relationships were only evident after adjustment for gestational age, presumably because higher maternal BMI is also, in some cases, associated with pre-term deliveries.
    Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1017557
  • Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1017558
  • Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1018819
  • Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1018820
  • [Show abstract] [Hide abstract]
    ABSTRACT: Information on the safety of first-trimester exposure to diagnostic magnetic resonance imaging (MRI) remains scarce. We are reporting a case series of 15 consecutive pregnant women who underwent an MRI scan with a 1.5-Tesla scanner of either the head (n = 5), cervical spine (n = 4), lumbar spine (n = 4), pelvis (n = 1) or knee (n = 1) in their first trimester of pregnancy (mean gestational age at exposure: 3.8 weeks). Patients were prospectively followed up until the completion of their pregnancy. Two cases received gadolinium as a contrast agent. There were 15 babies born alive. Of them, one baby was born with the left kidney not visualised by ultrasound examination, and another one with an overlapping toe in the right foot. None of these abnormalities were considered by the authors related to the MRI exposure. In conclusion, our study provides support to published preliminary evidence regarding the safety of MRI in the first-trimester pregnant women.
    Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1017559
  • Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1018818
  • Journal of Obstetrics and Gynaecology 06/2015; DOI:10.3109/01443615.2015.1017561
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to investigate the potential relationship between acylation-stimulating protein (ASP), insulin resistance, lipometabolism, the intrauterine metabolic environment and fetal growth in well-controlled gestational diabetes mellitus (GDM) women. A total of 55 well-controlled GDM women, 66 pregnant women with normal glucose tolerance (NGT) and their newborns, were included in this study. Fasting maternal and cord blood ASP, serum lipid profiles, glucose level, insulin level, HOMA-IR, in addition to neonatal anthropometry data, were measured. Maternal blood ASP in GDM is higher than that in NGT. In the GDM group, maternal blood ASP has a positive correlation with TG, FFA and HOMA-IR. Maternal and cord blood ASP levels of LGA fetuses correlate with elevated birth weight and SF4. Similarly, cord blood ASP levels of LGA fetuses also correlate with birth weight and SF4 in the NGT group. The maternal blood ASP level of GDM mothers is associated with lipometabolism, insulin resistance and LGA fetal growth. Nevertheless, the cord blood ASP level correlates with FFA of GDM mothers, LGA fetal growth of GDM and NGT mothers. ASP may be a biomarker for evaluating insulin resistance of GDM and LGA fetal growth.
    Journal of Obstetrics and Gynaecology 05/2015; 35(4). DOI:10.3109/01443615.2014.960376
  • [Show abstract] [Hide abstract]
    ABSTRACT: In post-menopausal period vulvo-vaginal atrophy (VVA)-related symptoms may seriously affect women's quality of life. Hormonal replacement therapy effectively relieves these symptoms but it is not always safe or accepted, and a non-hormonal treatment is often needed instead. Over a period of 12 weeks, we tested the effect of a twice-a-week vulvo-vaginal application of a hyaluronic acid, AC collagen, isoflavones and vitamins-based cream (Perilei Pausa®) on 35 women in post-menopausal period, reporting VVA-related symptoms. After 12 weeks of treatment with Perilei Pausa® a significant improvement in vaginal dryness, vulvo-vaginal itching, dyspareunia (P < 0.001), dysuria (P = 0.02), nocturia (P = 0.009) and pollakiuria (P = 0.005) was reported by the women. Colposcopical score assessing the intensity of atrophic colpitis, cervico-vaginal paleness and petechiae was also reduced (P = 0.037, P = 0.016 and P = 0.032, respectively). No significant difference in terms of maturation value of cervico-vaginal epithelium was observed. In conclusion, Perilei Pausa® may represent an effective and safe alternative treatment of symptomatic VVA in post-menopausal women.
    Journal of Obstetrics and Gynaecology 05/2015; DOI:10.3109/01443615.2015.1014326
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to compare the quality of life (QoL) between cervical cancer patients treated with systematic nerve-sparing radical hysterectomy (SNSRH) and modified radical hysterectomy (MRH). A total of 127 patients with early cervical cancer treated with radical hysterectomy (RH) were included in the study. The patients were divided into two groups: MRH group (n = ) and SNSRH group (n = ). The patients’ QoL scores were assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 questionnaire (Chinese version). The overall QoL scores were no different between the SNSRH and MRH groups in preoperative period (P > 0.05). In postoperative period, the overall QoL score in SNSRH group was slightly lower than that in MRH group at different follow-up time, but there was no difference between two groups (P > 0.05). Patients with early cervical cancer subjected to SNSRH or MRH are satisfied with their overall QoL scores. QoL may be negatively impacted by the cancer itself, surgery and adjuvant therapy.
    Journal of Obstetrics and Gynaecology 05/2015; DOI:10.3109/01443615.2015.1017556
  • [Show abstract] [Hide abstract]
    ABSTRACT: Obstetric anal sphincter injuries (OASIS) represent a serious morbidity that can cause short- and long-term consequences. It has attracted attention leading to the development of a national guideline by the Royal College of Obstetricians and Gynaecologists (RCOG). The aim of this study was to establish the current management of these injuries in hospitals across the UK. An anonymous self-construct questionnaire was posted to clinical directors/lead obstetricians in all hospitals in the UK and a total of 104 out of 233 (44.6%) questionnaires were returned. Over 90% of respondents' hospitals had protocols that required repair in theatre, as well as the prescription of laxatives and antibiotics and included these injuries in the risk management list. More than half of the respondents' hospitals did not have a dedicated perineal trauma clinic or used symptoms and quality of life questionnaires, endoanal scans or anal manometry routinely at follow-up. Over a third of respondents indicated that their units did not provide any training on repair of OASIS and did not have a multidisciplinary meeting involving colorectal surgeons. More effort is needed to improve all these aspects of care.
    Journal of Obstetrics and Gynaecology 04/2015; 35(3):229-34. DOI:10.3109/01443615.2014.954098
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the study was to evaluate sexual functions of pregnant women and to determine the factors affecting their sexual function. The cross-sectional study recruited 286 pregnant women from a hospital. To collect data, ‘Patient Information Form’, ‘State Anxiety Inventory’ and ‘Female Sexual Function Index’ were used. The mean age of women was 29.15 ± 4.85 and 77.6% of them presented with sexual dysfunction. Having partner at advanced age, a history of miscarriage, a history of health problem during previous pregnancy and a high level of anxiety were found to be factors negatively affecting sexual function. Health professionals should be aware of a number of risk factors that may contribute to sexual dysfunction in pregnant women.
    Journal of Obstetrics and Gynaecology 02/2015; DOI:10.3109/01443615.2015.1006596